Skip to content
Open access

Microbiota-derived deoxycholic and lithocholic acids attenuate diabetic kidney disease through suppression of podocyte ferroptosis via TGR5-SLC7A11 interaction

Nov 2026 · Frontiers in Microbiology · Vol 17 · 0 citations · 64 references

TL;DR

A gut–kidney axis was identified in which P. goldsteinii derived bile acids regulated the TGR5-SLC7A11 macromolecular interaction to suppress podocyte ferroptosis, thereby attenuating DKD progression.

Abstract

Diabetic kidney disease (DKD) is related to gut dysbiosis, yet the specific causative microbes remain unclear. This study integrated multi-omics, including 16S rRNA sequencing, metagenomics, and bile acid metabolomics on fecal samples from DKD patients and mice. Parabacteroides goldsteinii ( P. goldsteinii ) was orally administered to DKD mice, with assessment of podocyte injury, glomerular function, renal inflammation, and gut barrier integrity. In this study, we found a significant depletion of the gut commensal P. goldsteinii in both murine models and patients with DKD. Oral administration of P. goldsteinii ameliorated podocyte injury, glomerular dysfunction, renal inflammation, and gut barrier disruption in diabetic mice. The protective effects were mediated by microbially derived bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA), which activate Takeda G protein-coupled receptor 5 (TGR5), with the combined treatment producing greater protective effects than either bile acid alone. Furthermore, inhibition of bile acid hydrolysis (BSH) activity blocked the production of DCA/LCA and eliminated the renal benefits of P. goldsteinii . Mechanistically, DCA and LCA inhibited ferroptosis by promoting the interaction between TGR5 and SLC7A11 in podocytes. This interaction may contribute to the preservation of SLC7A11 function and enhancement of cellular antioxidant capacity, thereby attenuating iron-dependent lipid peroxidation. Podocyte-specific knockdown of TGR5 abolished the renoprotection conferred by P. goldsteinii and DCA/LCA. Collectively, our work identified a gut–kidney axis in which P. goldsteinii –derived bile acids regulated the TGR5-SLC7A11 macromolecular interaction to suppress podocyte ferroptosis, thereby attenuating DKD progression. These findings revealed a functional interaction between TGR5 and SLC7A11 and highlighted its regulation by microbial metabolites as a potential therapeutic mechanism for DKD.

Read PDF

Similar papers

Open access Oct 2026

Targeting the γ-glutamylcysteine-ferroptosis axis protects diabetic podocytes by dual-regulation of SAT1 and SLC7A11/GPX4

Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease worldwide, yet the mechanisms driving its progression are poorly understood. Here, through integrated multi-omics analyses of clinical serum samples and db/db mice, we identified a marked depletion of the glutathione biosynthetic inter...

Dan-Dan Xie, Si-Fan Guo, Hao Li et al. · 0 citations
Open access Oct 2026

Live combined bifidobacterium attenuates rivaroxaban-associated colonic bleeding in mice: evidence for a substantial gut microbiota-dependent component

Rivaroxaban, a direct oral anticoagulant (DOAC), is widely prescribed for the prevention and treatment of thromboembolic disorders. However, its use is associated with an increased risk of gastrointestinal bleeding, the mechanisms of which remain incompletely understood. Effective strategies to relief such bleeding are...

Xiao-Wen Chen, Yu-Ze Lin, You-Qi Huang et al. · 0 citations
Oct 2026

Allobaculum stercoricanis and Its Postbiotics Alleviate Dextran Sulfate Sodium (DSS)-Induced Colitis through the Regulation of theTLR4/NF-κB Signaling Pathway.

It is demonstrated that live Allobaculum stercoricanis and its two postbiotic preparations and its two postbiotic preparationseffectively alleviated dextran sulfate sodium (DSS)-induced colitis in mice, and hypothesize that α-MCA may contribute to ameliorating intestinal inflammation through engagement of FXR and suppr...

Teng Wang, Jian-Tang Wang, Bing-Xin Huangfu et al. · 0 citations
Review Open access Nov 2026

Gut microbiota-associated metabolites and microbial products in diabetic kidney disease: linking intestinal dysbiosis, inflammation, and renal fibrosis

Diabetic kidney disease (DKD) is a major microvascular complication of diabetes and a leading cause of chronic kidney disease and end-stage kidney disease. Although hyperglycemia, oxidative stress, inflammation, podocyte injury, tubular damage, and renal fibrosis are central to DKD progression, these mechanisms do no...

Xiao-Xiao Yu, Hai-Na Liang, Zhen-Zhen Lin et al. · 0 citations
Oct 2026

Tauroursodeoxycholic acid ameliorates DSS-induced ulcerative colitis via regulating TLR4/NLRP3/pyroptosis axis and Keap1/Nrf2 pathway and restoring gut barrier function.

Tauroursodeoxycholic acid (TUDCA) is a naturally occurring endogenous hydrophilic bile acid with therapeutic potential for ulcerative colitis (UC). However, the potential mechanism of its anti-UC effect remains unclear. Hence, this study investigated the therapeutic efficiency of TUDCA on dextran sulfate sodium (DSS)-i...

Jing-Yuan Liu, Xin-He Wang, Jia-Ying Wang et al. · 0 citations
Sep 2026

Oligosaccharides from Dendrobium officinale Ameliorate Metabolic Dysfunction in db/db Mice by Modulating Gut Microbiota, Short-Chain Fatty Acid Production, and Intestinal Barrier Integrity.

It is suggested that DOO1 may alleviate T2DM-related metabolic disorders by modulating gut microbiota and host metabolism by modulating gut microbiota and host metabolism.

Yuan Li, Tong Gao, Z. Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.